Had the now-scrapped changes to FoI laws been in place in recent years, it is likely that the previously unlawful arrangements for the Opiate Dependence Treatment Program and the employment workaround that led a health department official to secretly release confidential company pricing information, leading to its publication in the infamous 'Vancouver' poster, would never have been exposed.
Labor’s FoI backdown is a welcome victory for transparency and accountability
March 10, 2026 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Labor’s FoI backdown is a welcome victory for transparency and accountability
March 10, 2026 - - Latest News -
Mark Butler steps in to block eye injection funding change after patient warnings
March 10, 2026 - - Latest News -
Pharmac says new agreement has improved access to treatment for New Zealanders
March 10, 2026 - - Latest News -
Island Pharmaceuticals expands antiviral program through Burnet Institute collaboration
March 9, 2026 - -
New cancer research highlights potential of narmafotinib to koost KRAS Inhibitor therapies
March 9, 2026 - - Australian Biotech -
Lateral Pharma secures key U.S. patent for novel neuropathic pain therapy
March 9, 2026 - - Australian Biotech -
Nanosonics achieves key FDA clearance as CORIS Endoscope coverage expands
March 9, 2026 - - Australian Biotech

